Month: November 2021
-
Novo Nordisk Buys RNA Biotech in $3.3B Deal
Global drug maker Novo Nordisk is acquiring biotechnology company Dicerna Pharmaceuticals Inc. in an all-cash deal valued at $3.3 billion.
-
Synthetic Bio Milk Company Gains $13M in Seed Funds
A start-up enterprise creating milk and dairy products with proteins derived from engineered microorganisms is raising $13 million in seed funds.
-
Small Biz Grant Funds Long-Term Spasticity Implant
A developer of treatments for neurological disorders received National Institutes of Health funding for an implant treating spasticity for up to six months.
-
Ultimate Guide to Managing Your Online Business
There are many pitfalls that newcomers to e-commerce face when they decide to take the plunge into starting up their online store or blog.
-
New Company to Develop Synthetic Antibody Therapies
A new business is underway to develop and commercialize treatments for Covid-19 and other diseases based on synthetic antibody proteins.
-
Infographic – Unvaccinated Driving New Covid-19 Cases
Data released by the U.S. Centers for Disease Control and Prevention show new Covid-19 infections are concentrated largely among unvaccinated people.
-
Targeted Immunotherapy Shown to Shrink, Stop Tumors
Results from tests with lab mice show an experimental targeted cancer therapy invoking the immune system shrinks tumors and prevents their recurrence.
-
Trial Identifies Biomarkers for Quick Concussion Test
A clinical trial reveals glycan compounds found in saliva and urine as indicators of traumatic brain injury, helping create a quick diagnostic for the condition.
-
Trial Shows Psilocybin Drug Helps Reduce Depression
A clinical trial shows a drug derived from the hallucinogenic compound psilocybin reduces symptoms of depression, when part of a therapy program.
-
Chip Device Simulates Coronavirus Gut Symptoms
Biomedical engineers found a chip device with intestinal tissue can simulate coronavirus infections and symptoms in the gut, and test possible treatments.